ISMP Launches the 2023-24 Targeted Medication Safety Best Practices for Community Pharmacy
This column was prepared by the Institute for Safe Medication Practices (ISMP), an ECRI affiliate. The Institute for Safe Medication Practices (ISMP) has launched the 2023-24 Targeted Medication Safety Best Practices for Community Pharmacy (Best Practices). The purpose of these Best Practices is to identify, inspire, and mobilize widespread, national adoption of consensus-based best practices […]
Read More ›ISMP Safety Brief: Confusion Among the Many Humira Products With More Biosimilars on the Horizon
This column was prepared by the Institute for Safe Medication Practices (ISMP), an ECRI affiliate. A specialty pharmacy reported concerns with look-alike packaging with the many presentations of Humira® (adalimumab), which is used for nine different autoimmune indications in both pediatric and adult populations. The manufacturer produces 20 different prefilled syringe and pen carton configurations. […]
Read More ›ISMP: Common Workaround Contributes to Override of Barcode Alert
This column was prepared by the Institute for Safe Medication Practices (ISMP), an ECRI affiliate. A specialty pharmacy filled a prescription for Jakafi® (ruxolitinib) 5 mg tablets with 15 mg tablets by mistake and shipped it to the patient. Jakafi is a kinase inhibitor used to treat myelofibrosis and polycythemia vera in adults, and graft-versus-host […]
Read More ›ISMP: Restarting Clozapine Too Rapidly Can Cause Severe Cardiovascular Effects
This column was prepared by the Institute for Safe Medication Practices (ISMP), an ECRI affiliate. A patient presented to a hospital with agitation and confusion. He had a history of bipolar disorder for which he had been prescribed (off-label) the antipsychotic clozapine (CLOZARIL®). However, he had not taken the clozapine for several weeks more than […]
Read More ›ISMP: Respond to consumers’ error concerns with empathy and honesty
This column was prepared by the Institute for Safe Medication Practices, an ECRI affiliate. The Institute for Safe Medication Practices (ISMP) receives frequent reports of medication errors directly from patients. While patients are understandably concerned about errors, the patients who report to us are usually more upset about the response (or lack of) from the […]
Read More ›ISMP Provides Safe Practice Recommendations to Prevent COVID-19 and Flu Vaccine Mix-Ups
This column was prepared by the Institute for Safe Medication Practices (ISMP), an ECRI affiliate. Multiple mix-ups between the pediatric formulation (ages five through 11 years; orange cap and label border) and the formulation for individuals 12 years old or older of the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) Vaccine have been reported to the Institute […]
Read More ›